CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in OCUL — Ocular Therapeutix, Inc
CIK 884546
SAN FRANCISCO, CA
Position in OCUL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,058,361
+$2,682,192 QoQ
Shares Held
1,533,438
+4.9% QoQ
Ownership
0.698%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 257 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OCUL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,344,284,536 across 299 Biotechnology names. OCUL ranks #84 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in OCUL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,058,361 | 1,533,438 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,376,169 | 1,461,177 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $17,729,947 | 1,460,457 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $13,140,764 | 1,124,103 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $10,165,822 | 1,095,455 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $8,156,772 | 1,112,793 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $9,662,881 | 1,131,485 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $9,661,002 | 1,110,460 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,080,599 | 450,380 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,848,627 | 313,036 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $986,560 | 221,202 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $673,263 | 214,415 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,106,381 | 214,415 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,086,932 | 206,249 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $574,726 | 204,529 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $833,266 | 200,787 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $805,483 | 200,369 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $995,281 | 201,067 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,345,858 | 193,093 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,508,410 | 250,841 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $3,536,846 | 249,425 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,976,093 | 242,297 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,490,848 | 168,640 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,122,398 | 147,490 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,103,283 | 132,447 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $547,578 | 110,622 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||